Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. Thailand Legal Cannabis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Thailand Legal Cannabis: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Thailand Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Thailand Legal Cannabis Market, by Source, 2018 to 2030
4.5. Hemp
4.5.1. Hemp Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Hemp oil
4.5.2.1. Hemp oil Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Industrial Hemp
4.5.3.1. Industrial Hemp Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Marijuana
4.6.1. Marijuana Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Flower
4.6.2.1. Flower Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Oil and Tinctures
4.6.3.1. Oil and Tinctures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Thailand Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Derivatives Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Thailand Legal Cannabis Market, by Derivatives, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. THC
5.6.1. THC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Thailand Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Thailand Legal Cannabis Market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Thailand Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2024 & 2030
7.3. Segment Dashboard
7.4. Thailand Legal Cannabis Market, by End Use, 2018 to 2030
7.5. Industrial
7.5.1. Industrial market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Recreational
7.6.1. Recreational market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Medical
7.7.1. Medical market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Chronic Pain
7.7.2.1. Chronic Pain market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Depression and Anxiety
7.7.3.1. Depression and Anxiety market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. Arthritis
7.7.4.1. Arthritis market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.5. Post Traumatic Stress Disorder (PTSD)
7.7.5.1. Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.6. Cancer
7.7.6.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.7. Chronic Pain
7.7.7.1. Chronic Pain market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.8. Migraines
7.7.8.1. Migraines market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.9. Epilepsy
7.7.9.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.10. Multiple Sclerosis
7.7.10.1. Multiple Sclerosis market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.11. AIDS
7.7.11.1. AIDS market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.12. Amyotrophic Lateral Sclerosis
7.7.12.1. Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.13. Tourettes
7.7.13.1. Tourettes market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.14. Diabetes
7.7.14.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.15. Glaucoma
7.7.15.1. Glaucoma market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.16. Parkinson's
7.7.16.1. Parkinson's market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. PharmaHemp
8.3.1.1. Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Tilray Brands
8.3.2.1. Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Canopy Growth Corporation
8.3.3.1. Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Medipharm Labs
8.3.4.1. Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Epic Systems Corporation
8.3.5.1. Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Cresco Labs
8.3.6.1. Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Extractas
8.3.7.1. Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. BOL Pharma
8.3.8.1. Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Elixinol
8.3.9.1. Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Dr. CBD Innovation Center
8.3.10.1. Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. SAPPE
8.3.11.1. Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Osotspa Public Company Limited
8.3.12.1. Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Thailand legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Thailand legal cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 5 Thailand legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 6 Thailand legal cannabis market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Thailand legal cannabis market: market outlook
Fig. 9 Thailand legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Thailand legal cannabis market driver impact
Fig. 14 Thailand legal cannabis market restraint impact
Fig. 15 Thailand legal cannabis market strategic initiatives analysis
Fig. 16 Thailand legal cannabis market: Source movement analysis
Fig. 17 Thailand legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Thailand legal cannabis market: Cultivation movement analysis
Fig. 25 Thailand legal cannabis market: Cultivation outlook and key takeaways
Fig. 26 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 27 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 28 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 29 Thailand legal cannabis market: Derivatives movement analysis
Fig. 30 Thailand legal cannabis market: Derivatives outlook and key takeaways
Fig. 31 CBD market estimates and forecasts, 2018 - 2030
Fig. 32 THC market estimates and forecasts, 2018 - 2030
Fig. 33 Others market estimates and forecasts, 2018 - 2030
Fig. 34 Thailand legal cannabis market: End-use movement analysis
Fig. 35 Thailand legal cannabis market: End-use outlook and key takeaways
Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 41 Post-Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 45 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 49 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 53 Others market estimates and forecasts, 2018 - 2030
Fig. 54 Key company categorization